News Column

Kelun H1 Net Up 0.47%

August 28, 2014



SICHUAN, August 28, SinoCast -- Sichuan Kelun Pharmaceutical (SZSE: 002422) achieved sales revenue of CNY 3.967 billion in the first half of this year, growing 24.70% year on year.

Net profit attributable to shareholders reached CNY 537 million, growing 0.47%.

The new factory launched by the company in Kazakhstan in 2012, with a total of investment of CNY 70 million, built an anti-tumor injection production line and a plastic-bottle infusion production line meeting with the EU GMP standard. The plastic-bottle infusion production line has annual production capacity of 60 million bottles of infusion.

As of June 30, 2014, the Kazakhstan project has been fully completed and the plastic-bottle infusion production line has officially come into production.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Sinocast Health Care & Medicine Beat (China)


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters